Form 20FR12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001140361-24-043618
Filing Date
2024-10-17
Accepted
2024-10-17 16:05:33
Documents
49

Document Format Files

Seq Description Document Type Size
1 20FR12B ny20034211x3_20fr12b.htm 20FR12B 7800316
2 EXHIBIT 1.1 ny20034211x3_ex1-1.htm EX-1.1 1616
3 EXHIBIT 1.2 ny20034211x3_ex1-2.htm EX-1.2 787455
4 EXHIBIT 2.1 ny20034211x3_ex2-1.htm EX-2.1 282837
5 EXHIBIT 4.1 ny20034211x3_ex4-1.htm EX-4.1 500741
6 EXHIBIT 4.2 ny20034211x3_ex4-2.htm EX-4.2 598832
7 EXHIBIT 4.3 ny20034211x3_ex4-3.htm EX-4.3 141712
8 EXHIBIT 4.4 ny20034211x3_ex4-4.htm EX-4.4 425928
9 EXHIBIT 4.5 ny20034211x3_ex4-5.htm EX-4.5 286375
10 EXHIBIT 4.6 ny20034211x3_ex4-6.htm EX-4.6 564078
11 EXHIBIT 4.7 ny20034211x3_ex4-7.htm EX-4.7 321816
12 EXHIBIT 4.8 ny20034211x3_ex4-8.htm EX-4.8 306549
13 EXHIBIT 4.9 ny20034211x3_ex4-9.htm EX-4.9 177611
14 EXHIBIT 4.10 ny20034211x3_ex4-10.htm EX-4.10 237511
15 EXHIBIT 4.11 ny20034211x3_ex4-11.htm EX-4.11 173522
16 EXHIBIT 4.12 ny20034211x3_ex4-12.htm EX-4.12 143820
17 EXHIBIT 4.13 ny20034211x3_ex4-13.htm EX-4.13 48558
18 EXHIBIT 4.14 ny20034211x3_ex4-14.htm EX-4.14 971444
19 EXHIBIT 4.15 ny20034211x3_ex4-15.htm EX-4.15 987584
20 EXHIBIT 4.16 ny20034211x3_ex4-16.htm EX-4.16 974202
21 EXHIBIT 4.17 ny20034211x3_ex4-17.htm EX-4.17 891484
22 EXHIBIT 8.1 ny20034211x3_ex8-1.htm EX-8.1 6395
23 EXHIBIT 15.1 ny20034211x3_ex15-1.htm EX-15.1 1725
24 ny20034211x3_ex1-1image01.jpg GRAPHIC 1075188
25 ny20034211x3_ex1-1image02.jpg GRAPHIC 782451
26 ny20034211x3_ex1-2image01.jpg GRAPHIC 8526
27 ny20034211x3_ex2-1img01.jpg GRAPHIC 39791
28 ny20034211x3_ex2-1img02.jpg GRAPHIC 4498
29 ny20034211x3_ex4-1image01.jpg GRAPHIC 6709
30 ny20034211x3_ex4-3image01.jpg GRAPHIC 106756
31 ny20034211x3_ex4-3image02.jpg GRAPHIC 13400
32 ny20034211x3_ex4-3image03.jpg GRAPHIC 4030
33 ny20034211x3_ex4-4image01.jpg GRAPHIC 10748
34 ny20034211x3_ex4-6image01.jpg GRAPHIC 6611
35 ny20034211x3_ex4-6image02.jpg GRAPHIC 8927
36 ny20034211x3_ex4-6image03.jpg GRAPHIC 2088
37 ny20034211x3_ex4-6image04.jpg GRAPHIC 12802
38 ny20034211x3_ex4-7image01.jpg GRAPHIC 12289
39 ny20034211x3_ex4-7image02.jpg GRAPHIC 12417
40 ny20034211x3_ex4-9image01.jpg GRAPHIC 30535
41 ny20034211x3_ex4-9image02.jpg GRAPHIC 3319
42 ny20034211x3_ex4-10image01.jpg GRAPHIC 1828
43 ny20034211x3_ex4-10image02.jpg GRAPHIC 4466
44 ny20034211x3_ex4-10image03.jpg GRAPHIC 14282
45 ny20034211x3_ex4-11image01.jpg GRAPHIC 4809
46 ny20034211x3_ex4-12image01.jpg GRAPHIC 7100
47 ny20034211x3_ex4-16img001.jpg GRAPHIC 1181
48 ny20034211x3_ex4-16img002.jpg GRAPHIC 2115
49 ny20034211x3_linechart01.jpg GRAPHIC 417160
  Complete submission text file 0001140361-24-043618.txt   20201926
Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855
Telix Pharmaceuticals Ltd (Filer) CIK: 0002007191 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: 20FR12B | Act: 34 | File No.: 001-42128 | Film No.: 241377659
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)